Chemokine expression in tumor-to-tumor metastasis
- Authors:
- Julio S.N. Peguero
- Luis H. Camacho
- Bonnie Kemp
- Luis T. Campos
View Affiliations
Affiliations: Oncology Consultants P.A., Houston, TX 77024, USA. jupesn@yahoo.com
- Published online on: May 1, 2010 https://doi.org/10.3892/ol_00000079
-
Pages:
449-452
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Chemokines play an important role in cancer metastasis by modulating the directional cell movement and migration of tumor cells. The most commonly overexpressed chemokine receptor in human cancer is CXCR4. Once activated by its ligand CXCL12 (stromal cell-derived factor-1 ligand/SDF1), CXCR4 stimulates several key migratory, proliferative and survival signaling cellular pathways. CXCR4 is expressed in small-cell lung carcinoma (SCLC) cells and other tumors. To further characterize the role of chemokines in tumor-to-tumor metastasis, we analyzed the tissue expression of CXCR4 and CXCL12 in the surgical specimen of a patient with this phenomenon. We performed immunohistochemical analysis for the expression of CXCR4 and CXCL12 in metastatic tumor tissue of a 69-year-old Caucasian male with extensive SCLC metastatic to a renal oncocytoma. The oncocytoma tissue harboring SCLC showed CXCL12 expression, but not CXCR4. A high expression of the two molecules was found in a normal renal parenchymal control. Our results suggest that CXCR4 and CXCL12 plays a role in this condition, but their expression may be affected by the microenvironment of the harboring malignancy. Further characterization of these phenomena is needed to shed light on the biological mechanisms of tumor metastasis.
View References
|
1
|
Burger JA and Kipps TJ: CXCR4: a key
receptor in the crosstalk between tumor cells and their
microenvironment. Blood. 5:1761–1767. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zlotnik A: Chemokines in neoplastic
progression. Semin Cancer Biol. 3:181–185. 2004. View Article : Google Scholar
|
|
3
|
Hartmann TN, Burger JA, Glodek A, Fujii N
and Burger M: CXCR4 chemokine receptor and integrin signaling
co-operate in mediating adhesion and chemoresistance in small cell
lung cancer (SCLC) cells. Oncogene. 27:4462–4471. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Campbell LV Jr, Gilbert E, Chamberlain CR
Jr and Watne AL: Metastases of cancer to cancer. Cancer. 3:635–643.
1968. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hart IR: ‘Seed and soil’ revisited:
mechanisms of site-specific metastasis. Cancer Metastasis Rev.
1:5–16. 1982.
|
|
6
|
Tanaka T, Bai Z, Srinoulprasert Y, Yang
BG, Hayasaka H and Miyasaka M: Chemokines in tumor progression and
metastasis. Cancer Sci. 6:317–322. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 7:540–550. 2004. View Article : Google Scholar
|
|
8
|
Singh EO, Benson RC Jr and Wold LE:
Cancer-to-cancer metastasis. J Urol. 2:340–342. 1984.
|
|
9
|
Ben-Izhak O and Lichtig C: Renal
oncocytoma harbouring metastatic lung carcinoma. Case report. Scand
J Urol Nephrol. 4:317–318. 1990.PubMed/NCBI
|
|
10
|
Altinoz MA, Santaguida C, Guiot MC and Del
Maestro RF: Spinal hemangioblastoma containing metastatic renal
cell carcinoma in von Hippel-Lindau disease. Case report and review
of the literature. J Neurosurg Spine. 6:495–500. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koeman JM, Russell RC, Tan MH, Petillo D,
Westphal M and Koelzer K: Somatic pairing of chromosome 19 in renal
oncocytoma is associated with deregulated EGLN2-mediated
[corrected] oxygen-sensing response. PLoS Genet.
9:e10001762008.PubMed/NCBI
|
|
12
|
Ginouves A, Ilc K, Macias N, Pouyssegur J
and Berra E: PHDs overactivation during chronic hypoxia
‘desensitizes’ HIFalpha and protects cells from necrosis. Proc Natl
Acad Sci USA. 12:4745–4750. 2008.PubMed/NCBI
|
